The management of hiv-hodgkin lymphoma

Marcus Hentrich, Michele Spina

Research output: Chapter in Book/Report/Conference proceedingChapter


Hodgkin lymphoma (HL) is one of the most common non-AIDS-defining malignancies in the setting of HIV. Patients usually present with advanced-stage disease and median CD4 cell counts roughly between 150 and 250/μL. Since the introduction of combined antiretroviral therapy (cART), the prognosis of patients with HIV-HL has markedly improved. Standard curative-intent therapy and modern cART has resulted in outcomes that are similar to that reported in the general population.

Original languageEnglish
Title of host publicationHematologic Malignancies
Number of pages13
Publication statusPublished - 2020

Publication series

NameHematologic Malignancies
ISSN (Print)2197-9766
ISSN (Electronic)2197-9774


  • Autologous stem cell transplantation
  • Brentuximab vedotin
  • HIV
  • HIV-associated Hodgkin lymphoma
  • Hodgkin lymphoma

ASJC Scopus subject areas

  • Hematology
  • Oncology


Dive into the research topics of 'The management of hiv-hodgkin lymphoma'. Together they form a unique fingerprint.

Cite this